Wegovy is produced by Novo Nordisk — here's what that actually means for your treatment

The myth: several companies make Wegovy, so you can shop around for a cheaper version

This is the most persistent confusion around semaglutide, and it's worth correcting clearly. Wegovy is not a generic drug. It is a branded biological medicine manufactured by Novo Nordisk, and Novo Nordisk alone holds the UK marketing authorisation for its use in weight management. There is no cheaper own-brand equivalent sitting in a warehouse. When an online seller offers "semaglutide" for weight loss at a dramatically lower price, without reference to a legitimate prescription or a pharmacy you can verify, that is a red flag, not a bargain. The MHRA has seized large quantities of fake weight-loss pens in recent years, some containing dangerous contents. The safe route is a prescription from a GPhC-registered pharmacy sourcing through the licensed UK supply chain.

You can check whether an online pharmacy holds a valid GPhC registration in under a minute using the GPhC pharmacy register. If a seller isn't listed there, don't proceed.

What Novo Nordisk actually makes: Wegovy versus the other semaglutide products

Novo Nordisk produces semaglutide in several formulations, but their licences are not interchangeable. Ozempic is also semaglutide, but it is licensed for type 2 diabetes in the UK, not weight management, the MHRA is explicit on this. Rybelsus is an oral semaglutide tablet licensed for type 2 diabetes at 3mg, 7mg and 14mg doses. Wegovy is the weight-management product. Its injection form runs from 0.25mg up to the recently approved 7.2mg maintenance dose; the full range of licensed semaglutide products is a genuinely useful thing to understand before a consultation, because prescribers sometimes field questions about switching. For anyone focused on weight management, the correct product is Wegovy, and the dose a prescriber chooses will depend on tolerability and clinical response, not on what happens to be cheapest at the time.

On 11 June 2026 the MHRA also approved Wegovy tablets (oral semaglutide, 25mg maintenance dose) for weight management, the first oral GLP-1 medicine licensed for this purpose in the UK. That too is a Novo Nordisk product, with its own distinct dosing schedule and no refrigeration requirement. It is a different formulation from the injection, not a substitute dose.

Where Wegovy is manufactured and why that's relevant to supply

Novo Nordisk's primary manufacturing base for semaglutide is in Denmark, with production sites across Europe supporting global demand. Where Wegovy is produced has practical consequences: global shortages in 2022 and 2023 reflected how quickly demand outpaced what a single manufacturer's supply chain could deliver. The situation has eased in the UK for most doses, but specific strengths can still be intermittently constrained. This is one reason why a reputable prescribing service will not promise that a particular dose or pen format is guaranteed to be in stock, availability is confirmed at the point of dispensing. Anyone claiming to hold unlimited supply of a specific high-demand strength deserves a degree of scepticism.

The production process for semaglutide is complex by pharmaceutical standards, which is part of why there is no quick route to generic equivalents even as patents evolve. Biosimilar development takes years of regulatory work.

How the manufacturer's licence affects what you pay and where you can get it

Because Novo Nordisk is the sole licensed manufacturer for weight-management semaglutide in the UK, the wholesale cost of Wegovy is set by their pricing decisions. Eli Lilly made headlines in August 2025 when they raised the UK list price of Mounjaro significantly; similar dynamics apply to any single-manufacturer product. Private treatment prices reflect this cost, plus the clinical, dispensing and aftercare infrastructure wrapped around a legitimate prescription. For context on what private weight-loss treatment typically costs, the Wegovy cost guide covers the honest picture without pretending there are dramatic savings to be found.

At nume (at our GPhC-registered pharmacy (registration 9012878, verifiable at the GPhC register)) Wegovy is sourced through Novo Nordisk's authorised UK supply chain. One transparent price covers the consultation, prescription and next-working-day tracked delivery. If you want to understand how the clinical side works before anything else, our clinical team and the semaglutide overview are good starting points. The full picture on treatment options is at our consultation page, which is also where a free assessment begins, if you're ready. As the NHS semaglutide guidance confirms, this is a prescription-only medicine; a prescriber reviews suitability before anything is dispensed.